Literature DB >> 11558980

Improving the quality of pain treatment by a tailored pain education programme for cancer patients in chronic pain.

R de Wit1, F van Dam, S Loonstra, L Zandbelt, A van Buuren, K van der Heijden, G Leenhouts, H Duivenvoorden, H Huijer Abu-Saad.   

Abstract

Educational interventions, aiming to increase patients' knowledge and attitude regarding pain, can affect pain treatment. The purpose of this study was to evaluate the effects of a Pain Education Programme (PEP), on adequacy of pain treatment, and to describe characteristics predicting change in adequacy. The PEP consists of a multi-method approach in which patients are educated about the basic principles regarding pain, instructed how to report pain in a pain diary, how to communicate about pain, and how to contact healthcare providers. The effects of the PEP were evaluated taking into consideration the lack of well-established outcome measures to evaluate adequacy of pain treatment, the lack of long-term follow-up, and the influence of missing data.A prospective, randomized study was utilized in which 313 chronic cancer patients were followed-up until 8 weeks postdischarge. Adequacy of pain treatment was evaluated by means of the Amsterdam Pain Management Index (APMI), consisting of an integrated score of patients' Present Pain Intensity, Average Pain Intensity, and Worst Pain Intensity, corrected for patients' Tolerable Present Pain, with the analgesics used by the patient. At pretest, 60% of the patients in the hospital were treated inadequately for their pain. Postdischarge, the control group patients were significantly more inadequately treated at 2 weeks after discharge (56% vs 41%), at 4 weeks after discharge (62% vs 42%) and at 8 weeks after discharge (57% vs 51%) than the intervention group patients. While the level of inadequacy in the control groups remained relatively stable at all assessment points, a slight increase in the percentage of patients being treated inadequately was found in the intervention group patients over time. A beneficial effect of the PEP was found for patients both with and without district nursing. Variables predicting an improvement in adequacy of pain treatment consisted of the PEP, the APMI score at baseline, patients' level of physical functioning, patients' level of social functioning, the extent of adherence to pain medication, patients' pain knowledge, and the amount of analgesics used. These findings suggest that quality of pain treatment in cancer patients with chronic pain can be enhanced by educating patients about pain and improving active participation in their own pain treatment. The benefit from the PEP, however, decreases slightly over time, pointing at a need for ongoing education. Copyright 2001 European Federation of Chapters of the International Association for the Study of Pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11558980     DOI: 10.1053/eujp.2001.0239

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  11 in total

Review 1.  Optimal patient education for cancer pain: a systematic review and theory-based meta-analysis.

Authors:  N Marie; T Luckett; P M Davidson; M Lovell; S Lal
Journal:  Support Care Cancer       Date:  2013-10-02       Impact factor: 3.603

2.  Efficacy of pain education in cancer patients: a meta-analysis of randomized controlled trials.

Authors:  Hyun Jung Jho; Seung-Kwon Myung; Yoon-Jung Chang; Dae-Hyun Kim; Doo Heun Ko
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

3.  Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study.

Authors:  Shih-Feng Cho; Kun-Ming Rau; Yu-Yun Shao; Chia-Jui Yen; Ming-Fang Wu; Jen-Shi Chen; Cheng-Shyong Chang; Su-Peng Yeh; Tzeon-Jye Chiou; Ruey-Kuen Hsieh; Ming-Yang Lee; Yung-Chuan Sung; Kuan-Der Lee; Pang-Yu Lai; Ming-Sun Yu; Wen-Li Hwang; Ta-Chih Liu
Journal:  Support Care Cancer       Date:  2018-08-15       Impact factor: 3.603

Review 4.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

Review 5.  Meta-analysis of psychosocial interventions to reduce pain in patients with cancer.

Authors:  Sherri Sheinfeld Gorin; Paul Krebs; Hoda Badr; Elizabeth Amy Janke; Heather S L Jim; Bonnie Spring; David C Mohr; Mark A Berendsen; Paul B Jacobsen
Journal:  J Clin Oncol       Date:  2012-01-17       Impact factor: 44.544

6.  Patients' perspectives on pain.

Authors:  Cecilia Norrbrink; Monika Löfgren; Judith P Hunter; Jaqueline Ellis
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

7.  Cancer Health Empowerment for Living without Pain (Ca-HELP): study design and rationale for a tailored education and coaching intervention to enhance care of cancer-related pain.

Authors:  Richard L Kravitz; Daniel J Tancredi; Richard L Street; Donna Kalauokalani; Tim Grennan; Ted Wun; Christina Slee; Dionne Evans Dean; Linda Lewis; Naomi Saito; Peter Franks
Journal:  BMC Cancer       Date:  2009-09-09       Impact factor: 4.430

8.  Head and neck cancer survivors' pain in France: the VICAN study.

Authors:  Justin Dugué; Maxime Humbert; Marc-Karim Bendiane; Anne-Déborah Bouhnik; Emmanuel Babin; Idlir Licaj
Journal:  J Cancer Surviv       Date:  2021-02-26       Impact factor: 4.442

9.  On the reproducibility of meta-analyses: six practical recommendations.

Authors:  Daniël Lakens; Joe Hilgard; Janneke Staaks
Journal:  BMC Psychol       Date:  2016-05-31

10.  Randomized clinical trial of an intensive nursing-based pain education program for cancer outpatients suffering from pain.

Authors:  Evelien H van der Peet; Marieke H J van den Beuken-van Everdingen; Jacob Patijn; Harry C Schouten; Maarten van Kleef; Annemie M Courtens
Journal:  Support Care Cancer       Date:  2008-12-23       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.